The company has substantially improved this development of the new solution for amyloid heart disease, leveraging the compound. Preliminary clinical data suggests significant benefits for individuals diagnosed by a https://bridgebio214693.look4blog.com/79954962/company-progresses-amyloidosis-therapy-with-the-drug